SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-005232
Filing Date
2021-01-08
Accepted
2021-01-08 16:25:31
Documents
17
Period of Report
2021-01-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d75815d8k.htm   iXBRL 8-K 29883
2 EX-1.1 d75815dex11.htm EX-1.1 145260
3 EX-5.1 d75815dex51.htm EX-5.1 8606
4 EX-99.1 d75815dex991.htm EX-99.1 9083
8 GRAPHIC g75815g0108115932899.jpg GRAPHIC 1422
9 GRAPHIC g75815g74e82.jpg GRAPHIC 2267
  Complete submission text file 0001193125-21-005232.txt   365414

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20210107.xsd EX-101.SCH 3059
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20210107_lab.xml EX-101.LAB 18137
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20210107_pre.xml EX-101.PRE 11400
10 EXTRACTED XBRL INSTANCE DOCUMENT d75815d8k_htm.xml XML 3349
Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 21517728
SIC: 2836 Biological Products, (No Diagnostic Substances)